Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

Coronavirus disease 2019 (COVID-19) continues to pose a threat to public health with the potential for the emergence of new variants. Vaccines are the milestones to control and slow down the damage of the pandemic. As of January 2021, a two-dose regimen with CoronaVac was authorized in Turkey. Due t...

Descrición completa

Detalles Bibliográficos

Principais autores:	Meliha Cagla Sonmezer, Gulcin Telli Dizman, Enes Erul, Taha Koray Sahin, Tuğba Saricaoglu, Alparslan Alp, Mine Durusu Tanriover, Omrum Uzun, Serhat Unal, Murat Akova
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-07-01
Series:	Vaccines
Assuntos:	COVID-19 vaccine booster dose third dose vaccine effectiveness
Acceso en liña:	https://www.mdpi.com/2076-393X/10/7/1140
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!